Detalles de la búsqueda
1.
Effects of fenofibric acid on carotid intima-media thickness in patients with mixed dyslipidemia on atorvastatin therapy: randomized, placebo-controlled study (FIRST).
Arterioscler Thromb Vasc Biol
; 34(6): 1298-306, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24743431
2.
Study design, rationale, and baseline characteristics: evaluation of fenofibric acid on carotid intima-media thickness in patients with type IIb dyslipidemia with residual risk in addition to atorvastatin therapy (FIRST) trial.
Cardiovasc Drugs Ther
; 26(4): 349-58, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22622962
3.
Achievement of lipid targets with the combination of rosuvastatin and fenofibric Acid in patients with type 2 diabetes mellitus.
Cardiovasc Drugs Ther
; 25(1): 47-57, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21174145
4.
Long-term efficacy of adding fenofibric acid to moderate-dose statin therapy in patients with persistent elevated triglycerides.
Cardiovasc Drugs Ther
; 25(1): 59-67, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21416219
5.
Efficacy and safety of fenofibric acid in combination with atorvastatin and ezetimibe in patients with mixed dyslipidemia.
Am Heart J
; 160(4): 759-66, 2010 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-20934572
6.
Efficacy and safety of rosuvastatin and fenofibric acid combination therapy versus simvastatin monotherapy in patients with hypercholesterolemia and hypertriglyceridemia: a randomized, double-blind study.
Am J Cardiovasc Drugs
; 10(3): 175-86, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20524719
7.
Efficacy and safety of fenofibric acid co-administered with low- or moderate-dose statin in patients with mixed dyslipidemia and type 2 diabetes mellitus: results of a pooled subgroup analysis from three randomized, controlled, double-blind trials.
Am J Cardiovasc Drugs
; 10(2): 73-84, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20136164
8.
Efficacy and safety of rosuvastatin 5 mg in combination with fenofibric acid 135 mg in patients with mixed dyslipidemia - a phase 3 study.
Cardiovasc Drugs Ther
; 24(5-6): 421-8, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-20953684
9.
Year two assessment of fenofibric acid and moderate-dose statin combination: a phase 3, open-label, extension study.
Clin Drug Investig
; 30(1): 51-61, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-19995098
10.
Efficacy and safety of ABT-335 (fenofibric acid) in combination with simvastatin in patients with mixed dyslipidemia: a phase 3, randomized, controlled study.
Am Heart J
; 157(1): 195-203, 2009 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19081418
11.
ABT-335, the choline salt of fenofibric acid, does not have a clinically significant pharmacokinetic interaction with rosuvastatin in humans.
J Clin Pharmacol
; 49(1): 63-71, 2009 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-18952910
12.
Evaluation of a new formulation of fenofibric acid, ABT-335, co-administered with statins : study design and rationale of a phase III clinical programme.
Clin Drug Investig
; 28(10): 625-34, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-18783301
13.
Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial.
JAMA
; 290(2): 238-47, 2003 Jul 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-12851279
14.
A randomized, double-blind study of fenofibric acid plus rosuvastatin compared with rosuvastatin alone in stage 3 chronic kidney disease.
Clin Ther
; 35(8): 1186-98, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23891363
15.
Combination rosuvastatin plus fenofibric acid in a cohort of patients 65 years or older with mixed dyslipidemia: subanalysis of two randomized, controlled studies.
Clin Cardiol
; 33(10): 609-619, 2010 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-20960535
16.
Efficacy and safety of ABT-335 (fenofibric acid) in combination with rosuvastatin in patients with mixed dyslipidemia: a phase 3 study.
Atherosclerosis
; 204(1): 208-15, 2009 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-18996523
17.
Efficacy and safety of ABT-335 (fenofibric acid) in combination with atorvastatin in patients with mixed dyslipidemia.
Am J Cardiol
; 103(4): 515-22, 2009 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-19195513
18.
Efficacy and safety of fenofibric acid in combination with a statin in patients with mixed dyslipidemia: Pooled analysis of three phase 3, 12-week randomized, controlled studies.
J Clin Lipidol
; 3(2): 125-37, 2009 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21291802
19.
Long-term safety and efficacy of fenofibric acid in combination with statin therapy for the treatment of patients with mixed dyslipidemia.
J Clin Lipidol
; 2(6): 426-35, 2008 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21291776
Resultados
1 -
19
de 19
1
Próxima >
>>